GDNF Induces Recovery of the Nigrostriatal Dopaminergic System in the Rat Brain Following Intracerebroventricular or Intraparenchymal Administration

[1]  I. Date,et al.  The effect of intrastriatal single injection of GDNF on the nigrostriatal dopaminergic system in hemiparkinsonian rats: behavioral and histological studies using two different dosages , 2000, Neuroscience Research.

[2]  J. Qian,et al.  Behavioral and Cellular Protection of Rat Dopaminergic Neurons by an Adenoviral Vector Encoding Glial Cell Line-Derived Neurotrophic Factor , 1998, Experimental Neurology.

[3]  I. Date,et al.  GDNF administration induces recovery of the nigrostriatal dopaminergic system both in young and aged parkinsonian mice , 1998, Neuroreport.

[4]  A. Björklund,et al.  Studies on Neuroprotective and Regenerative Effects of GDNF in a Partial Lesion Model of Parkinson's Disease , 1997, Neurobiology of Disease.

[5]  D. Hilt,et al.  Glial Cell Line-Derived Neurotrophic Factor: A Novel Therapeutic Approach to Treat Motor Dysfunction in Parkinson's Disease , 1997, Experimental Neurology.

[6]  S. Jiao,et al.  Glial cell line-derived neurotrophic factor: distribution and pharmacology in the rat following a bolus intraventricular injection , 1997, Brain Research.

[7]  S. Jiao,et al.  Pharmacological characterization of glial cell line-derived neurotrophic factor (GDNF): implications for GDNF as a therapeutic molecule for treating neurodegenerative diseases , 1996, Cell and Tissue Research.

[8]  M. Pelleymounter,et al.  Glial cell line-derived neurotrophic factor sustains axotomized basal forebrain cholinergic neurons in vivo: dose-response comparison to nerve growth factor and brain-derived neurotrophic factor. , 1996, The Journal of pharmacology and experimental therapeutics.

[9]  B. Hoffer,et al.  Functional recovery in parkinsonian monkeys treated with GDNF , 1996, Nature.

[10]  A. Granholm,et al.  Glial cell line‐derived neurotrophic factor supports survival of injured midbrain dopaminergic neurons , 1995, The Journal of comparative neurology.

[11]  Shelley R. Winn,et al.  Implantation of encapsulated catecholamine and GDNF-producing cells in rats with unilateral dopamine depletions and parkinsonian symptoms , 1995, Experimental Neurology.

[12]  D. Gash,et al.  GDNF protects nigral dopamine neurons against 6-hydroxydopamine in vivo , 1995, Brain Research.

[13]  L. Olson,et al.  Protection and repair of the nigrostriatal dopaminergic system by GDNF in vivo , 1995, Nature.

[14]  I. Date,et al.  Efficacy of pretransection of peripheral nerve for promoting the survival of cografted chromaffin cells and recovery of host dopaminergic fibers in animal models of Parkinson's disease , 1994, Neuroscience Research.

[15]  L. Olson,et al.  Glial Cell Line-Derived Neurotrophic Factor Is Expressed in the Developing but Not Adult Striatum and Stimulates Developing Dopamine Neurons in Vivo , 1993, Experimental Neurology.

[16]  Greg A. Gerhardt,et al.  Correlation of apomorphine- and amphetamine-induced turning with nigrostriatal dopamine content in unilateral 6-hydroxydopamine lesioned rats , 1993, Brain Research.

[17]  I. Date,et al.  The influence of donor age on cografting of adrenal medulla with pretransected peripheral nerve , 1993, Brain Research.

[18]  J. Cadet,et al.  The intrastriatal 6-hydroxydopamine model of hemiparkinsonism: quantitative receptor autoradiographic evidence of correlation between circling behavior and presynaptic as well as postsynatic nigrostriatal markers in the rat , 1992, Brain Research.

[19]  Fred H. Gage,et al.  Partial lesion of the substantia nigra: relation between extent of lesion and rotational behavior , 1991, Brain Research.

[20]  J. Cadet,et al.  Long-term behavioral and biochemical effects of 6-hydroxydopamine injections in rat caudate-putamen , 1991, Brain Research Bulletin.

[21]  I. Date,et al.  Cografts of adrenal medulla with peripheral nerve enhance the survivability of transplanted adrenal chromaffin cells and recovery of the host nigrostriatal dopaminergic system in MPTP-treated young adult mice , 1990, Brain Research.

[22]  I. Date,et al.  Long-term effect of MPTP in the mouse brain in relation to aging: neurochemical and immunocytochemical analysis , 1990, Brain Research.

[23]  S. Wiegand,et al.  Use of cryoprotectant to maintain long-term peptide immunoreactivity and tissue morphology , 1986, Peptides.

[24]  U. Ungerstedt,et al.  Postsynaptic supersensitivity after 6-hydroxy-dopamine induced degeneration of the nigro-striatal dopamine system. , 1971, Acta physiologica Scandinavica. Supplementum.

[25]  G. Paxinos,et al.  The Rat Brain in Stereotaxic Coordinates , 1983 .